Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Navigation
Selected Language
English (United States)
All Languages
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
A coalition of fourteen Democratic lawmakers signed a letter sent to President Biden and Vice President Harris in November 2024 urging the current leaders to expedite expanding pardons for those charged with cannabis-related offenses, as well as putting into effect updated guidelines deprioritizing federal cannabis convictions and prosecutions.
Despite a change in administration, cannabis advocates are still working for significant reform. As such, we’ve compiled a list of the fourteen congress members acting as signatories to the recent pro-cannabis letter, summarizing their respective career efforts in support of cannabis legal reform, both nationally and within their own jurisdictions.
About The Congress Letter to President Biden on Clemency
In spite of Biden’s previous praiseworthy and revolutionary federal pardons for cannabis convicts and the president’s support in favor of rescheduling cannabis from Schedule I to Schedule III under the 1971 Controlled Substances Act (CSA), legislators were consistently working to keep Biden accountable to his pro-cannabis campaign promises.
Shortly before his administration came to a close, a collection of congressional signatories emphasized to the president that rescheduling efforts alone are insufficient to comprehensively or effectively address the greater issues associated with the ongoing federal criminalization of cannabis classified under the legal category of “marijuana.” Nor can this federal action address the complicated and problematic disparity between federal and state cannabis laws, which would largely remain unaffected by federal rescheduling of the drug.
The coalition of congressional lawmakers, led by Sen. Elizabeth Warren and Rep. Barbara Lee, called for more comprehensive reform action to address the harms of federal cannabis prohibition policies. The letter urges Biden to further expand marijuana pardons, which have already been taking place under the president’s term. The lawmakers furthermore urge Biden to deprioritize federal cannabis prosecutions. This letter expresses that such actions must take place before President Biden’s term came to an end in January 2025.
Regretfully, Biden’s term ended without much of a response to this letter. Despite granting more acts of clemency than any previous chief executive on record, his final days in office did not offer much progress for cannabis reform.
Now, with President Trump’s mixed legacy concerning cannabis and new leaders taking charge in the Drug Enforcement Agency and other relevant organizations, the future of reform is cloudy.
In light of this uncertain moment in cannabis legality, we’re keeping eyes on the US lawmakers who have historically worked to enact lasting and effective change for federal cannabis regulatory change.
Members of Congress Who Signed the Letter
The following members of Congress signed the pro-cannabis letter. For most of these legislators, it wasn’t their first time advocating for cannabis reform.
Elizabeth Warren (D-MA):
As a leading voice in promoting cannabis reform, Warren has contributed to the creation of the 2018 Strengthening the Tenth Amendment Through Entrusting States (STATES) Act. This bill was intended to eliminate various regulatory controls and criminal penalties under the CSA, preventing legal interference regarding a number of cannabis-related activities that comply with state or tribal laws. Namely. as long as states and tribes do not participate in cannabis-related activity that endangers human life or involves the employment of or selling of marijuana to minors, such persons acting in compliance with State or tribal laws relating to marijuana activities should not face criminal penalties.
See If You Qualify For Medical Marijuana -Select Your State!
Barbara Lee (D-CA):
Barbara Lee has been a long-time supporter of cannabis legalization efforts and equity in the cannabis industry and legal regulatory system. Lee has also served as Co-chair of the historical Congressional Cannabis Caucus, a forum for elected officials to collaborate on how to address our outdated federal marijuana criminal laws. In addition, Rep. Lee was responsible for introducing the Marijuana Justice Act, which received the highest number of congressional co-sponsorships of any legislation intended to remove marijuana from the Controlled Substances Act in history.
Bernie Sanders (I-VT):
Sanders has been a consistent supporter for full federal legalization of marijuana, having advocated for de-scheduling cannabis and ending the drug’s prohibition entirely. In his presidential campaigns, Sanders made cannabis reform a pivotal issue and significantly raised national awareness about the problems generated and perpetuated by national cannabis prohibition. His 2019 campaign was revolutionary in promoting a promise to legalize the drug in all 50 states within 100 days of his term.
Cory Booker (D-NJ):
The New Jersey congressman has been a strong proponent of social equity in cannabis reform, recognizing the impact of prohibition on various disadvantaged communities. Booker even introduced the 2022 Cannabis Administration and Opportunity Act, intended to federally decriminalize and de-schedule cannabis from the CSA and support expungement programs for individuals subject to cannabis convictions.
Ron Wyden (D-OR):
Another congressional co-sponsor of the STATES Act, Sen. Wyden also sponsored the Marijuana Revenue and Regulation Act, which was aimed at removing cannabis from the list of scheduled substances under the CSA, as well as establish federal taxation programs and regulation of cannabis.
John Hickenlooper (D-CO):
The former governor of Colorado has played a pivotal role in implementing revolutionary recreational cannabis legalization in the state. The senator has also taken part in advocacy for performing further research into the societal impacts of legalization. In addition, Sen. Hickenlooper has been an advocate for federal reforms to take place based on Colorado’s successful legalization efforts.
Earl Blumenauer (D-OR):
Along with Sen. Lee, former US Representative Blumenauer has acted as a co-founder of the Congressional Cannabis Caucus and as a primary sponsor of numerous cannabis reform bills. One of these bills was the 2022 Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which sought to remove cannabis from the list of scheduled substances under the CSA and eliminates criminal penalties for individuals involved in activity associated with the manufacture, distribution, or possession of marijuana.
Ilhan Omar (D-MN):
Another advocate for the MORE Act, Omar has additionally supported efforts to grant clemency for non-violent drug offenders. Rep. Omar has been a supporter of various decriminalization and clemency efforts, with a particular emphasis on the importance of racial equity and restorative justice in pursuing national cannabis reform.
Among these prolific senators and representatives are other major figures in US congress who have advocated for, supported, and made impacts for cannabis legalization in the United States and in their specific regions including: Kirsten Gillibrand (D-NY), Ben Ray Luján (D-NM), Jan Schakowsky (D-IL), Dina Titus (D-NV), Jim McGovern (D-MA), and Eleanor Holmes Norton (D-DC).
Concluding Reflections:
The letter sent to President Biden and Vice President Harris represents a pivotal moment in the ongoing efforts to advocate for and reform federal cannabis law and policy in the United States. Whether or not the actions taken by these congress members were successful at this point, the collective efforts of these fourteen congressional lawmakers highlight the urgent need to address the lingering consequences of prohibition, particularly the medical, racial, and social inequities that persist in accordance with current cannabis prohibition legislation.
Many of these lawmakers have been instrumental, both nationally and locally, in advancing federal and state-level cannabis legislation and their achievements — which range from innovating new state legalization frameworks and taxation regulations, to championing federal de-scheduling efforts and equity initiatives—represent intense commitment to the future transformation of marijuana law and cannabis policy into a new era.
By drafting and signing this critical document, congress has underscored unprecedented support for meaningful reform to cannabis legal policy in the US, where the federal government has been unwaveringly austere for decades, and the efforts of these members of congress sets the a new precedent for future progress. It is hopeful that such measures can fortify future momentum toward more equitable and appropriate responses and policies in US policy for cannabis laws in the United States for the coming generations.
Sheldon Sommer is a Southern Californian philosopher with a lifelong interest in the biological world. She is enthusiastic to contribute her fascination with philosophy, natural history, psychology, botany, biochemistry and other related topics to providing cannabis education for the similarly curious. Outside of writing, she enjoys painting, singing opera and Taylor Swift songs, as well as spending quality time with a certain beloved orange kitty cat.
What gives cannabis its powerful effects, rich aroma, and frosty appearance? The answer lies in crystal-like structures called trichomes that cover the surface of cannabis flowers. This is where the cannabis cultivation magic happens because they produce and store the majority of compounds responsible for the plant’s potency, flavor, and therapeutic benefits. Trichomes are the…
If pain is an aspect of your cannabis journey, you might be interested in a Green Dragon tincture. This homemade creation will not turn you into a magic dragon, but it could make you feel on top of the world if you are dealing with chronic pain. Pain can slow us down. When the body…
Sometimes, your urine has a strange, weed-like, or other abnormal smell, and you might not be sure what’s causing it. This common experience often leads to online searches driven by curiosity or concern about potential health issues. This article explores some of the most common reasons behind a cannabis-like urine odor and other types of…
As of April 2025, 39 states, three U.S. territories, and the District of Columbia have some form of medical cannabis program. Each program is unique, and some states only offer low-THC medical cannabis for those who qualify. But what does “low-THC cannabis” really mean? And what products can patients in these states actually purchase? We’re…
The debate about the safety of cannabis rages on, with more studies indicating that the herb may not be completely harmless. One particular study published as a preproof in JACC: Advances suggests a link between cannabis use and cardiovascular disease (CVD) events in adults under 50. While you might be skeptical about this claim, the…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.